Objective: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for essential tremor (ET) and tremor-dominant Parkinson's disease (PD), yet a substantial proportion of patients experience tremor recurrence over time. Reliable imaging biomarkers to predict long-term outcomes are lacking. The purpose of the study was to evaluate whether radiomic features extracted from 24-h post-treatment MRI can predict clinically relevant tremor recurrence at 12 months after MRgFUS thalamotomy, using a machine learning (ML) approach. Materials and methods: Retrospective, single-center study included 120 patients (61 ET, 59 PD) treated with unilateral MRgFUS Vim thalamotomy between February 2018 and June 2023. Tremor severity was assessed using part A of the Fahn–Tolosa–Marin Tremor Rating Scale (FTM-TRS) at baseline and 12 months. Recurrence was defined as an FTM-TRS part A score ≥ 3 at 12 months. Lesions were manually segmented on 24-h post-treatment T2-weighted MRI. Forty radiomic features (18 first-order, 22 texture GLCM from Laplacian of Gaussian–filtered images) were extracted. A linear Support Vector Classifier with leave-one-out cross-validation was used for classification. Model explainability was assessed using SHapley Additive exPlanations (SHAP). Results: Clinically relevant tremor recurrence occurred in 23 patients (19%). For the full cohort, the ML model achieved a balanced accuracy of 0.720, weighted F1-score of 0.737, and comparable sensitivity and specificity across classes. Performance was higher in PD (BA = 0.808, F1 = 0.793) than in ET (BA = 0.580, F1 = 0.696). The most predictive features were texture-derived GLCM metrics, particularly from edge-enhanced images, with first-order features contributing complementary information. No significant correlations were found between radiomic features and procedural parameters. Conclusion: Radiomic analysis of MRgFUS lesions on 24-h post-treatment MRI can provide early prediction of 12-month tremor recurrence, with higher predictive value in PD than in ET. Texture-based features may capture microstructural characteristics linked to treatment durability. This approach could inform post-treatment monitoring and individualized management strategies.
Innocenzi, A., Peluso, S., Bruno, F., Balducci, L., Rocchi, E., Bellini, M., et al. (2025). Radiomic signatures from postprocedural MRI thalamotomy lesion can predict long-term clinical outcome in patients with tremor after MRgFUS: a pilot study. FRONTIERS IN RADIOLOGY, 5, 1-9 [10.3389/fradi.2025.1683274].
Radiomic signatures from postprocedural MRI thalamotomy lesion can predict long-term clinical outcome in patients with tremor after MRgFUS: a pilot study
Peluso, SaraCo-primo
Formal Analysis
;Rocchi, EttoreFormal Analysis
;Castellani, Gastone;
2025
Abstract
Objective: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for essential tremor (ET) and tremor-dominant Parkinson's disease (PD), yet a substantial proportion of patients experience tremor recurrence over time. Reliable imaging biomarkers to predict long-term outcomes are lacking. The purpose of the study was to evaluate whether radiomic features extracted from 24-h post-treatment MRI can predict clinically relevant tremor recurrence at 12 months after MRgFUS thalamotomy, using a machine learning (ML) approach. Materials and methods: Retrospective, single-center study included 120 patients (61 ET, 59 PD) treated with unilateral MRgFUS Vim thalamotomy between February 2018 and June 2023. Tremor severity was assessed using part A of the Fahn–Tolosa–Marin Tremor Rating Scale (FTM-TRS) at baseline and 12 months. Recurrence was defined as an FTM-TRS part A score ≥ 3 at 12 months. Lesions were manually segmented on 24-h post-treatment T2-weighted MRI. Forty radiomic features (18 first-order, 22 texture GLCM from Laplacian of Gaussian–filtered images) were extracted. A linear Support Vector Classifier with leave-one-out cross-validation was used for classification. Model explainability was assessed using SHapley Additive exPlanations (SHAP). Results: Clinically relevant tremor recurrence occurred in 23 patients (19%). For the full cohort, the ML model achieved a balanced accuracy of 0.720, weighted F1-score of 0.737, and comparable sensitivity and specificity across classes. Performance was higher in PD (BA = 0.808, F1 = 0.793) than in ET (BA = 0.580, F1 = 0.696). The most predictive features were texture-derived GLCM metrics, particularly from edge-enhanced images, with first-order features contributing complementary information. No significant correlations were found between radiomic features and procedural parameters. Conclusion: Radiomic analysis of MRgFUS lesions on 24-h post-treatment MRI can provide early prediction of 12-month tremor recurrence, with higher predictive value in PD than in ET. Texture-based features may capture microstructural characteristics linked to treatment durability. This approach could inform post-treatment monitoring and individualized management strategies.| File | Dimensione | Formato | |
|---|---|---|---|
|
fradi-5-1683274.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
644.09 kB
Formato
Adobe PDF
|
644.09 kB | Adobe PDF | Visualizza/Apri |
|
Supplementary file 1.pdf
accesso aperto
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
65.43 kB
Formato
Adobe PDF
|
65.43 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


